American Health Packaging is recalling 6,344 cartons of Benzonatate Capsules, USP, 100 mg. The recall was issued because the medication was found to be superpotent, meaning the capsules contained a slightly higher amount of the active drug than allowed by specifications. Benzonatate is a prescription medication used to relieve coughs.
Taking a superpotent dose of benzonatate may lead to an increased risk of side effects or adverse reactions. No injuries or incidents have been reported to date.
You have 2 options:
Distributed by American Health Packaging. Carton NDC is 68084-214-01; Individual Dose NDC is 68084-214-11.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.